Walvax Biotechnology Co Ltd Class A 300142
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥11.20
- Day Range
- ¥11.12–11.31
- 52-Week Range
- ¥10.61–28.45
- Bid/Ask
- ¥11.18 / ¥11.19
- Market Cap
- ¥17.96 Bil
- Volume/Avg
- 11.1 Mil / 16.2 Mil
Key Statistics
- Price/Earnings (Normalized)
- 34.20
- Price/Sales
- 4.62
- Dividend Yield (Trailing)
- 0.09%
- Dividend Yield (Forward)
- 0.09%
- Total Yield
- 0.09%
Company Profile
Walvax Biotechnology Co Ltd is engaged in research and development, production and sales of vaccine products.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 2,388
- Website
- http://www.walvax.com
Comparables
Valuation
Metric
|
300142
|
300601
|
002880
|
---|---|---|---|
Price/Earnings (Normalized) | 34.20 | 30.36 | 30.52 |
Price/Book Value | 1.92 | 1.74 | 2.98 |
Price/Sales | 4.62 | 5.20 | 5.76 |
Price/Cash Flow | 20.96 | 19.97 | 18.34 |
Price/Earnings
300142
300601
002880
Financial Strength
Metric
|
300142
|
300601
|
002880
|
---|---|---|---|
Quick Ratio | 2.46 | 1.36 | 1.50 |
Current Ratio | 2.85 | 1.82 | 3.83 |
Interest Coverage | 47.19 | 6.43 | 14.52 |
Quick Ratio
300142
300601
002880
Profitability
Metric
|
300142
|
300601
|
002880
|
---|---|---|---|
Return on Assets (Normalized) | 3.37% | 3.75% | 7.55% |
Return on Equity (Normalized) | 5.57% | 5.79% | 10.65% |
Return on Invested Capital (Normalized) | 3.91% | 4.61% | 8.73% |
Return on Assets
300142
300601
002880
Drug Manufacturers - Specialty & Generic Industry Comparables
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|---|
Zoetis Inc Class A
ZTS
| Njmsvkwvqq | Vtq | $82.1 Bil | |||
Merck KGaA ADR
MKKGY
| Wlzghpmcyp | Pzbfkz | $73.2 Bil | |||
Haleon PLC ADR
HLN
| Kwglctqt | Qtpds | $41.0 Bil | |||
Viatris Inc
VTRS
| Zgdcdqj | Yxt | $14.4 Bil | |||
Dr Reddy's Laboratories Ltd ADR
RDY
| Prxmxrrpy | Phgn | $13.7 Bil | |||
Catalent Inc
CTLT
| Nxshnmmq | Jwgkzsf | $10.6 Bil | |||
Perrigo Co PLC
PRGO
| Xmxpmwt | Xxx | $3.8 Bil | |||
Prestige Consumer Healthcare Inc
PBH
| Zymfbgtf | Cfyntg | $3.5 Bil | |||
Curaleaf Holdings Inc
CURLF
| Mpnbpgj | Qcllc | $3.0 Bil | |||
Green Thumb Industries Inc
GTBIF
| Dywhlttbd | Cgtk | $2.7 Bil |